![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Tools
Tools
Preview |
PDF (Original Article)
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
7MB |
![[thumbnail of Supplementary Materials]](https://edoc.mdc-berlin.de/style/images/fileicons/other.png) |
Other (Supplementary Materials)
32MB |
| Item Type: | Article |
|---|---|
| Title: | SMER28 attenuates PI3K/mTOR signaling by direct inhibition of PI3K p110 delta |
| Creators Name: | Kirchenwitz, M., Stahnke, S., Prettin, S., Borowiak, M., Menke, L., Sieben, C., Birchmeier, C., Rottner, K., Stradal, T.E.B. and Steffen, A. |
| Abstract: | SMER28 (Small molecule enhancer of Rapamycin 28) is an autophagy-inducing compound functioning by a hitherto unknown mechanism. Here, we confirm its autophagy-inducing effect by assessing classical autophagy-related parameters. Interestingly, we also discovered several additional effects of SMER28, including growth retardation and reduced G1 to S phase progression. Most strikingly, SMER28 treatment led to a complete arrest of receptor tyrosine kinase signaling, and, consequently, growth factor-induced cell scattering and dorsal ruffle formation. This coincided with a dramatic reduction in phosphorylation patterns of PI3K downstream effectors. Consistently, SMER28 directly inhibited PI3Kδ and to a lesser extent p110γ. The biological relevance of our observations was underscored by SMER28 interfering with InlB-mediated host cell entry of Listeria monocytogenes, which requires signaling through the prominent receptor tyrosine kinase c-Met. This effect was signaling-specific, since entry of unrelated, gram-negative Salmonella Typhimurium was not inhibited. Lastly, in B cell lymphoma cells, which predominantly depend on tonic signaling through PI3Kδ, apoptosis upon SMER28 treatment is profound in comparison to non-hematopoietic cells. This indicates SMER28 as a possible drug candidate for the treatment of diseases that derive from aberrant PI3Kδ activity. |
| Keywords: | Phosphatidylinositol 3-Kinase (PI 3-Kinase), Mammalian Target of Rapamycin (mTOR), Autophagy, Receptor Tyrosine Kinase, Small Molecule, Actin, Hepatocyte Growth Factor/Scatter Factor (HGF/SF), Platelet-Derived Growth Factor-C (PDGF-C), Cell Proliferation, Cancer Biology |
| Source: | Cells |
| ISSN: | 2073-4409 |
| Publisher: | MDPI |
| Volume: | 11 |
| Number: | 10 |
| Page Range: | 1648 |
| Date: | 16 May 2022 |
| Official Publication: | https://doi.org/10.3390/cells11101648 |
| PubMed: | View item in PubMed |
Repository Staff Only: item control page
